Job: Adelaide-based life sciences leadership opportunity

CPR Pharma Services is a Clinical Research Organisation which offers specialised services supporting drug development for the pharmaceutical and biotechnology industry. Currently operating with an Interim CEO, the continuing success of the company means that it is poised…

Read More

Melbourne School of Population and Global Health – Short Courses

About the Health Economics Unit The Health Economics Unit undertakes a range of economic evaluation, health systems research, simulation modelling and risk prediction, health inequality, and methodological research. Our projects have informed policy-making decisions in a range of…

Read More

2018 ATSE Clunies Ross Award Recepients

2018 ATSE Clunies Ross Entrepreneur of the Year: Dr Erol Harvey FTSE TRANSLATING MICRO AND NANO TECHNOLOGY Scientist, educator and entrepreneur Dr Erol Harvey has made outstanding contributions to Australia through the world-leading microfluidic engineering company MiniFAB, his…

Read More

Cynata Announces Research Collaboration with University of New South Wales to Develop Stem Cell Therapies for Coronary Artery Disease

Melbourne, Australia; 18 June 2018: Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that it has commenced a preclinical research collaboration with UNSW Sydney (the University of New South Wales)…

Read More

Prana to commence Phase 1 clinical trial of PBT434 for treatment of parkinsonian diseases

Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has commenced for the first cohort of healthy volunteers Study conducted by leading Australian early phase clinical trial facility Nucleus Network,…

Read More

ASX 100 reaches 30 per cent target but board appointments slow

ASX 200 boards have made substantial progress since 2009 when the percentage of female directors stood at just 8.3%. It now stands at 27.7%.                     The Australian Institute of…

Read More

Job:  Senior Quality Associate

♦ Professional Growth Opportunity ♦ ASX Listed Pharmaceutical Company ♦ Flexible Working Environment The Company The Company is an Australian-based ASX listed pharmaceutical company that is developing high quality and clinically validated medicines. The Company is bringing together…

Read More

“Medicines Development for Global Health Secures U.S. FDA Approval For Moxidectin For The Treatment Of River Blindness”

MELBOURNE, GENEVA, and NEW YORK Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved moxidectin 8…

Read More

Piper Alderman Melbourne has relocated

From 4 June 2018 you will find them at Level 23, 459 Collins Street, Melbourne, 3000 Commencing Monday 4 June 2018, the Melbourne office of Piper Alderman will operate from Level 23, 459 Collins Street, Melbourne. This change will see…

Read More

Member news: Success story of a patient on GrunBiotic’s Neurofolin

Member news: Success story of a patient on GrunBiotic’s Neurofolin: https://www.mamamia.com.au/folate-depression/”

Read More

AdAlta secures key manufacturing agreements for AD-214

AdAlta secures key manufacturing agreements for AD-214 Please click here for an ASX announcement relating to the execution of key manufacturing agreements for AD-214

Read More

Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs

Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…

Read More

Home

News & opinion

Member Directory

Events